scispace - formally typeset
R

Roberto Chiesa

Researcher at Mario Negri Institute for Pharmacological Research

Publications -  91
Citations -  6112

Roberto Chiesa is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Endoplasmic reticulum & Mutant. The author has an hindex of 37, co-authored 91 publications receiving 5782 citations. Previous affiliations of Roberto Chiesa include University of Pavia & Jichi Medical University.

Papers
More filters
Journal ArticleDOI

Neurotoxicity of a prion protein fragment

TL;DR: It is reported here that neuronal death results from chronic exposure of primary rat hippocampal cultures to micromolar concentrations of a peptide corresponding to residues 106–126 of the amino-acid sequence deduced from human PrP complementary DNA.
Journal ArticleDOI

Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

TL;DR: It is reported that, in mice, acute intracerebroventricular injections of synthetic Aβ1–42 oligomers impaired consolidation of the long-term recognition memory, whereas mature Aβ 1–42 fibrils and freshly dissolved peptide did not, and it was confirmed that A β1– 42 oligomers interact with PrPC, with nanomolar affinity.
Journal ArticleDOI

Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35

TL;DR: The results confirm the potential pathogenic role of A beta in AD, and indicate that amyloid fibrils may induce neuronal death through a specific programmed process.
Journal ArticleDOI

Neurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation

TL;DR: Transgenic mice that express the mouse homolog of a mutant human PrP containing a nine octapeptide insertion associated with prion dementia are produced, establishing a new transgenic animal model of an inherited human prion disorder.
Journal ArticleDOI

Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation

TL;DR: It is reported here that mutant PrP molecules are delayed in their maturation to an endoglycosidase H-resistant form after biosynthetic labeling, suggesting that they are impaired in their exit from the endoplasmic reticulum (ER), but it is found that proteasome inhibitors have no effect on the maturation or turnover of either mutant or wild-type PrP molecule.